At a glance
ClinicalIndex Comparison RecordN/ACompleted· 134 enrolled
Drug / intervention
Lotrafilcon B sphere modified design contact lenses +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Daily Wear (DW) Evaluation of Lotrafilcon B in a Modified Design
In Brief
A clinical study evaluating Lotrafilcon B sphere modified design contact lenses and Lotrafilcon B sphere contact lenses for Myopia. Completed, enrolled 134 participants.
Detailed Summary
The purpose of this study is to demonstrate that Lotrafilcon B AIR OPTIX® AQUA sphere modified design lenses are noninferior to Lotrafilcon B AIR OPTIX® AQUA in overall lens fit by comparing the percent of subjects satisfying the "no re-fit" criteria in each treatment group.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJun 2014
First PostedJun 2014
Primary CompletionJul 2014
TodayJul 2026
First PostedJun 6, 2014
Enrollment StartJun 1, 2014
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 12.1 years ago
Interventions
Lotrafilcon B sphere modified design contact lensesdevice
Lotrafilcon B sphere contact lensesdevice